Advisers Find Yield in Medical Royalties

The Wall Street Journal | By Anna Prior

In today’s search for yield, some financial advisers are turning to drugs. Actually, they are steering their wealthy clients into a niche investment focused on the development and sale of drugs and medical devices.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.